Discover how the recent advancements in theranostics have revolutionized nuclear medicine through Prof. Pubul Núñez's insightful explanation.

Professor Nagarajah guides us through the latest developments in PSMA-targeting radiopharmaceuticals and shares his views on the role of dosimetry in radionuclide therapy.

Prof. Grana provides an overview of the main issues and challenges currently facing PRRT and its role in managing NETs.